110 related articles for article (PubMed ID: 15060072)
1. Peptide mapping of a novel discontinuous epitope of the major surface adhesin from Streptococcus mutans.
van Dolleweerd CJ; Kelly CG; Chargelegue D; Ma JK
J Biol Chem; 2004 May; 279(21):22198-203. PubMed ID: 15060072
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the conformational epitope of Guy's 13, a monoclonal antibody that prevents Streptococcus mutans colonization in humans.
van Dolleweerd CJ; Chargelegue D; Ma JK
Infect Immun; 2003 Feb; 71(2):754-65. PubMed ID: 12540555
[TBL] [Abstract][Full Text] [Related]
3. Specificity of monoclonal antibodies in local passive immunization against Streptococcus mutans.
Ma JK; Hunjan M; Smith R; Lehner T
Clin Exp Immunol; 1989 Sep; 77(3):331-7. PubMed ID: 2478321
[TBL] [Abstract][Full Text] [Related]
4. Characterization of epitopes recognized by anti-Streptococcus mutans P1 monoclonal antibodies.
McArthur WP; Rhodin NR; Seifert TB; Oli MW; Robinette RA; Demuth DR; Brady LJ
FEMS Immunol Med Microbiol; 2007 Aug; 50(3):342-53. PubMed ID: 17535300
[TBL] [Abstract][Full Text] [Related]
5. Expression of a functional single-chain Fv antibody on the surface of Streptococcus gordonii.
Giomarelli B; Maggi T; Younson J; Kelly C; Pozzi G
Mol Biotechnol; 2004 Oct; 28(2):105-12. PubMed ID: 15477649
[TBL] [Abstract][Full Text] [Related]
6. A mechanism of passive immunization with monoclonal antibodies to a 185,000 M(r) streptococcal antigen.
Lehner T; Ma JK; Kelly CG
Adv Exp Med Biol; 1992; 327():151-63. PubMed ID: 1295336
[TBL] [Abstract][Full Text] [Related]
7. A therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune response.
Robinette RA; Oli MW; McArthur WP; Brady LJ
Vaccine; 2011 Aug; 29(37):6292-300. PubMed ID: 21704107
[TBL] [Abstract][Full Text] [Related]
8. Generation of human antibody fragments against Streptococcus mutans using a phage display chain shuffling approach.
Kuepper MB; Huhn M; Spiegel H; Ma JK; Barth S; Fischer R; Finnern R
BMC Biotechnol; 2005 Jan; 5():4. PubMed ID: 15667665
[TBL] [Abstract][Full Text] [Related]
9. Induction of immune responses to functional determinants of a cell surface streptococcal antigen.
Todryk SM; Kelly CG; Munro GH; Lehner T
Immunology; 1996 Jan; 87(1):55-63. PubMed ID: 8666436
[TBL] [Abstract][Full Text] [Related]
10. Induced fit of an epitope peptide to a monoclonal antibody probed with a novel parallel surface plasmon resonance assay.
Baggio R; Carven GJ; Chiulli A; Palmer M; Stern LJ; Arenas JE
J Biol Chem; 2005 Feb; 280(6):4188-94. PubMed ID: 15556932
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the Streptococcus mutans P1 epitope recognized by immunomodulatory monoclonal antibody 6-11A.
Rhodin NR; Cutalo JM; Tomer KB; McArthur WP; Brady LJ
Infect Immun; 2004 Aug; 72(8):4680-8. PubMed ID: 15271929
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
Covaceuszach S; Cattaneo A; Lamba D
Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
[TBL] [Abstract][Full Text] [Related]
13. Fine Epitope Mapping of Monoclonal Antibodies to the DNA Repair Protein, RadA.
Stuart MK; Hudman DA; Nachtrab SN; Hiatt JL; Seo J; Pullen SJ; Sargentini NJ
Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):83-94. PubMed ID: 28581365
[TBL] [Abstract][Full Text] [Related]
14. G196 epitope tag system: a novel monoclonal antibody, G196, recognizes the small, soluble peptide DLVPR with high affinity.
Tatsumi K; Sakashita G; Nariai Y; Okazaki K; Kato H; Obayashi E; Yoshida H; Sugiyama K; Park SY; Sekine J; Urano T
Sci Rep; 2017 Mar; 7():43480. PubMed ID: 28266535
[TBL] [Abstract][Full Text] [Related]
15. Passive immunization against dental caries and periodontal disease: development of recombinant and human monoclonal antibodies.
Abiko Y
Crit Rev Oral Biol Med; 2000; 11(2):140-58. PubMed ID: 12002812
[TBL] [Abstract][Full Text] [Related]
16. Epitope mapping of Streptococcus mutans SR protein and human IgG cross-reactive determinants, by using recombinant proteins and synthetic peptides.
Gangloff S; M'Zoughi R; Lett E; Scholler M; Baer J; Pini A; Ogier J; Klein JP
J Immunol; 1992 May; 148(10):3249-55. PubMed ID: 1374451
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box.
Zhao M; Li XJ; Tang ZM; Yang F; Wang SL; Cai W; Zhang K; Xia NS; Zheng ZZ
J Biol Chem; 2015 Aug; 290(32):19910-22. PubMed ID: 26085097
[TBL] [Abstract][Full Text] [Related]
18. Clumping factor B, a fibrinogen-binding MSCRAMM (microbial surface components recognizing adhesive matrix molecules) adhesin of Staphylococcus aureus, also binds to the tail region of type I cytokeratin 10.
Walsh EJ; O'Brien LM; Liang X; Hook M; Foster TJ
J Biol Chem; 2004 Dec; 279(49):50691-9. PubMed ID: 15385531
[TBL] [Abstract][Full Text] [Related]
19. The reactivity of naturally sensitized human CD4 cells and IgG antibodies to synthetic peptides derived from the amino terminal sequences of a 3800 MW Streptococcus mutans antigen.
Childerstone A; Haron J; Lehner T
Immunology; 1990 Feb; 69(2):177-83. PubMed ID: 1689692
[TBL] [Abstract][Full Text] [Related]
20. A novel peptide isolated from a phage display peptide library with trastuzumab can mimic antigen epitope of HER-2.
Jiang B; Liu W; Qu H; Meng L; Song S; Ouyang T; Shou C
J Biol Chem; 2005 Feb; 280(6):4656-62. PubMed ID: 15536075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
